Coeptis Therapeutics Holdings Inc. Common Stock (COEP) is a publicly traded Healthcare sector company. As of May 21, 2026, COEP trades at $16.40 with a market cap of $102.06M and a P/E ratio of -6.51. COEP moved +1.05% today. Year to date, COEP is +6.49%; over the trailing twelve months it is +31.52%. Its 52-week range spans $2.31 to $21.41. Analyst consensus is buy with an average price target of $0.00. Rallies surfaces COEP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Z Squared Merges with Coeptis, Lists 51.5 Million Shares on Nasdaq on April 27: Z Squared has completed its business combination with Coeptis Therapeutics and will begin trading on the Nasdaq Global Market under the ticker ZSQR on April 27, 2026. Post-combination the company has 51.5 million common shares outstanding, with former Z Squared Opco shareholders owning 85% and existing public holders 15%.
| Metric | Value |
|---|---|
| Price | $16.40 |
| Market Cap | $102.06M |
| P/E Ratio | -6.51 |
| EPS | $-2.52 |
| Dividend Yield | 0.00% |
| 52-Week High | $21.41 |
| 52-Week Low | $2.31 |
| Volume | 111.93K |
| Avg Volume | 0 |
| Revenue (TTM) | $1.41M |
| Net Income | $-12.93M |
| Gross Margin | 87.22% |
1 analysts cover COEP: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $0.00.